Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: January 27, 2023

CLINICAL TRIALS PROFILE FOR IXABEPILONE

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

All Clinical Trials for Ixabepilone

Subscribe to access the full database, or Sign up for a Free Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00004927 ↗	BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy	Completed	Memorial Sloan Kettering Cancer Center	Phase 1	1999-07-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have advanced solid tumors that have not responded to previous therapy.
NCT00004927 ↗	BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy	Completed	National Cancer Institute (NCI)	Phase 1	1999-07-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have advanced solid tumors that have not responded to previous therapy.
NCT00004927 ↗	BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy	Completed	Bristol-Myers Squibb	Phase 1	1999-07-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have advanced solid tumors that have not responded to previous therapy.
NCT00004927 ↗	BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy	Completed	R-Pharm	Phase 1	1999-07-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have advanced solid tumors that have not responded to previous therapy.
NCT00005807 ↗	Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer	Completed	National Cancer Institute (NCI)	Phase 1	2000-07-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have metastatic, recurrent, or locally advanced, ovarian cancer, breast cancer, or metastatic or unresectable solid tumors.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Ixabepilone

Condition Name

Chart
Table

Condition Name for Ixabepilone
Intervention	Trials
Breast Cancer	23
Metastatic Breast Cancer	18
Unspecified Adult Solid Tumor, Protocol Specific	9
Stage IV Breast Cancer	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Ixabepilone
Intervention	Trials
Breast Neoplasms	47
Neoplasms	15
Carcinoma	12
Adenocarcinoma	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Ixabepilone

Trials by Country

Map
Table

Trials by Country for Ixabepilone
Location	Trials
United States	608
Italy	25
Japan	18
United Kingdom	17
Australia	14
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Ixabepilone
Location	Trials
California	30
New York	30
Maryland	29
Florida	28
Texas	26
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Ixabepilone

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Ixabepilone
Clinical Trial Phase	Trials
Phase 3	7
Phase 2	65
Phase 1/Phase 2	11
[disabled in preview]	31
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Ixabepilone
Clinical Trial Phase	Trials
Completed	82
Terminated	19
Active, not recruiting	5
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ixabepilone

Sponsor Name

Chart
Table

Sponsor Name for Ixabepilone
Sponsor	Trials
National Cancer Institute (NCI)	53
Bristol-Myers Squibb	28
R-Pharm	27
[disabled in preview]	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Ixabepilone
Sponsor	Trials
Industry	78
Other	71
NIH	54
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys

Dow

Merck

McKesson

AstraZeneca

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.